Cancer Research 68, 6873, September 1, 2008. doi: 10.1158/0008-5472.CAN-08-0547
© 2008 American Association for Cancer Research
Pontin and Reptin, Two Related ATPases with Multiple Roles in Cancer
Otmar Huber1,
Ludovic Ménard2,3,
Valérie Haurie2,3,
Alexandra Nicou2,3,
Danièle Taras2,3 and
Jean Rosenbaum2,3
1 Department of Laboratory Medicine and Pathobiochemistry, Charité-Universitätsmedizin Berlin, Berlin, Germany and 2 Institut National de la Santé et de la Recherche Médicale U889; and 3 Université Victor Segalen Bordeaux 2, Bordeaux, France
Requests for reprints: Jean Rosenbaum, Institut National de la Santé et de la Recherche Médicale U889, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. E-mail: jean.rosenbaum{at}gref.u-bordeaux2.fr.
 |
Abstract
|
|---|
Studies in model organisms or cultured human cells suggest potential implications in carcinogenesis for the AAA+ ATPases Pontin and Reptin. Both proteins are associated with several chromatin-remodeling complexes and have many functions including transcriptional regulation, DNA damage repair, and telomerase activity. They also interact with major oncogenic actors such as β-catenin and c-myc and regulate their oncogenic function. We only now begin to get insight into the role of Pontin and Reptin in human cancers. [Cancer Res 2008;68(17):6873–6]
|
Introduction
|
|---|
Pontin and Reptin are two related members of the AAA+ (ATPases associated with diverse cellular activities) superfamily sharing conserved Walker A and B motifs, arginine fingers, and sensor domains. Because both proteins were identified independently by several groups, multiple names exist in the literature and data bases (RuvBl1, Rvb1, Tip49a, NMP238, ECP54, TAP54
, and TIH1 for Pontin; RuvBl2, Tip49b, ECP51, TAP54, and TIH2 for Reptin). Pontin and Reptin share limited homology to the bacterial helicase RuvB, which is essentially involved in the catalysis of Holliday junction branch migration. Whereas the functional importance of the ATPase activity of both proteins has been clearly established by the expression of proteins mutated in the Walker A or B motifs, there is dispute whether they are indeed endowed with helicase activity. In the recent years, a number of studies have established that both proteins are essential for the viability and development of model organisms including S. cerevisiae, D. melanogaster, X. laevis, or D. rerio.
Pontin and Reptin normally are coexpressed and frequently share common binding partners. Formation of homomeric and heteromeric interactions between Pontin and/or Reptin has been reported but heteromeric complex formation is preferred as analyzed by coimmunoprecipitation from lysates of transfected cells. In vitro, Pontin and Reptin form hexameric or double hexameric ring systems (1). Most evidence points to an association of Pontin and Reptin in the cell nucleus with several types of high molecular weight complexes involved in chromatin remodeling and/or transcriptional regulation such as, in human, the hINO80, Tip60, SRCAP, and Uri1/Prefoldin complexes (1). It is, however, noteworthy that the multimeric status of Pontin and Reptin in the cytoplasm is not well defined. Some data even suggest that they are found in different subcellular locations in the course of cell division (2). The structural aspects of Pontin and Reptin and their functions in the regulation of transcription have been recently reviewed (1) and thus will not be addressed here in detail.
|
Expression in Cancer
|
|---|
Until recently, there were no data about the expression of Pontin and Reptin in human cancer. We performed a differential proteomic analysis of a few cases of human hepatocellular carcinoma (HCC) that were compared with the non–tumor-surrounding liver (3). This revealed an overexpression of Reptin in the index cases that led us to study a further 96 cases of human HCC with real-time PCR. It turned out that Reptin transcription was increased in 75% of the cases (same for Pontin;4 ref. 4) and that high levels of Reptin were correlated with a poor prognosis, independently of other prognosis variables. We have also investigated Pontin expression in a series of 34 colon cancer specimens and found it to be increased in more than 80% of the cases (5). The regulation of Reptin or Pontin expression has not been reported as such in other large series of tumors. However, reanalysis of microarray data available in the Oncomine database5 shows a deregulated expression of these proteins in several cancers such as bladder cancer and melanoma.
The mechanisms inducing overexpression of Reptin and Pontin in tumors are unknown and may be tumor-type specific. The Reptin gene is located on chromosome 19q13.3, a region not commonly affected in HCC, and it is thus unlikely that Reptin overexpression is consecutive to a gene amplification event. The same is true for the Pontin gene, which is located on chromosome 3q21. In contrast, Pontin is overexpressed in non–small cell lung cancer (6) where this locus is commonly amplified.
Unexpectedly, we detected strongly enhanced cytoplasmic expression of Reptin (4) and Pontin4 in liver cancer and of Pontin in colon cancer (5). All known functions of Pontin and Reptin are consistent with a nuclear localization, and both proteins indeed have been localized in the nucleus in many cell types from various organisms. On the other hand, both Reptin and Pontin can be found to be associated with the mitotic apparatus, although at different locations during mitosis, suggesting that they may play distinct roles during this process independently of their nuclear functions (2).
Because Pontin and Reptin expression seems to be increased in a large number of cancer types, these proteins may be of general interest for oncologists. The specific nuclear and nonnuclear functions of both proteins remain to be dissected and may elucidate important aspects about their roles in cancer cells.
|
Interactions with Mediators of Carcinogenesis
|
|---|
Numerous Pontin and Reptin interaction partners have known roles in cancer. The first hints suggesting a relationship between Pontin, Reptin, and cancer came with the discovery that both proteins interacted with β-catenin (7, 8) and c-myc (9). Moreover, expression of both proteins is regulated by c-myc (9). Pontin seems to be required for the transforming effect of c-myc (9), the viral oncoprotein E1A (10), or β-catenin (11). There are no similar data available for Reptin. On the other hand, in various assays, Reptin was found to antagonize the transcriptional effect of the T-cell factor/lymphoid enhancer factor-1-β-catenin complex, whereas Pontin potentiated it (8). However, more recently it was shown in metastatic prostate cancer cells that Reptin, but not Pontin, was recruited to the promoter of the metastasis suppressor gene KAI-1 in a complex with β-catenin and was required for the repressing effect of β-catenin on the transcription of this gene, possibly contributing to the enhanced invasive properties of tumor cells (12). The formation of this complex seems to depend on sumoylation of Reptin (13). Conversely, in nonmetastatic prostate cancer cells, Pontin, but not Reptin, is recruited to the same promoter in complex with the Tip60 histone acetyltransferase, although Pontin is not required for the activating effect of Tip60 on transcription (12). On the other hand, Pontin turned out to be a cofactor for the transcriptional activation of androgen receptor target genes in a sumoylation-dependent way (14).
Tip60 is a multifaceted protein that is also involved in DNA damage repair, where it operates within a multiprotein complex containing both Pontin and Reptin (15). Their likely role in the response to DNA damage is in agreement with the recent observations that both Pontin and Reptin seem to be phosphorylated by ataxia telangiectasia mutated (ATM)/ATM and Rad3-related following DNA damage (16) and that Pontin is required for Tip60 activity after DNA damage (17).
We have also shown that Pontin and Reptin bind the tumor suppressor Hint1 (histidine triad nucleotide-binding protein 1/protein kinase C inhibitor 1; ref. 18). Hint1 binding can disrupt the Pontin-Reptin interaction, but it is not known whether Reptin or Pontin modulates Hint1 functions. Reptin, but not Pontin, also interacts with the transcription factor activating transcription factor 2 (ATF-2; ref. 19), which can function either as a tumor susceptibility protein or as a tumor suppressor according to the cell type. Reptin interferes with the transcriptional activity of ATF-2, and this may participate in its function.
Thus, Pontin and Reptin interact with many established actors of carcinogenesis. Although they may seem to act antagonistically at the molecular level, they both are involved in events that favor tumor progression.
|
Roles in Cell Viability/Cell Death
|
|---|
As mentioned above, the absence of expression of either Pontin or Reptin impairs cell growth in several organisms. The presence of one protein cannot compensate for the deficiency of the other. Loss-of-function mutations in Walker domains have similar effects on growth as the absence of the protein, likely indicating a requirement for the ATPase activity. Conversely, overexpression of Pontin or Reptin in the Xenopus embryo leads to an increase in proliferation, an effect that is independent of the function of Walker domains but is likely instead related to interactions with c-myc (20).
Although interactions with c-myc may be involved (20, 21), the mechanisms through which Pontin and Reptin regulate cell growth remain incompletely understood. Several data point to a role in the G1 part of the cell cycle. Indeed, loss of Reptin in yeast induces a blockage in G1 (22). This is coherent with the observation that both proteins are involved in the transcriptional repression of p21, a repressor of the cyclin E/cyclin-dependent kinase-2 complex required for the G1-S transition (20). In human HCC cells, we have observed a concomitant block in G2-M after knockdown of Reptin.6 Intriguingly, abrogation of Pontin or Reptin expression has been shown to induce premature senescence, which may contribute to the observed effects on the cell cycle (23). This is in line with the very recent finding that Pontin and Reptin are required for the assembly and function of the telomerase complex (24).
Besides their role in regulating cell proliferation, both Pontin and Reptin are involved in the regulation of apoptosis. We observed that siRNA-mediated knockdown of Reptin in human HCC cells led to spontaneous apoptotic cell death (4). Similar results were obtained in other tumor cell lines, either hepatic or not (MCF-7).7 Conversely, transduction with a lentiviral vector coding Flag-tagged Reptin, which induced a moderate overexpression of Reptin, conferred an increased resistance to apoptotic cell death in HCC cells (4). Strikingly, Tyteca and colleagues. (25) found that siRNA-mediated knockdown of Reptin in the human osteosarcoma cell line U2OS had the opposite effect in decreasing UV-induced apoptosis. This discrepancy may be explained by the fact that UV-induced cell death is dependent on p53 activation, and Reptin acts as a partner in the Tip60 complex that functions as a coactivator of p53 (25). On the other hand, we have found that the spontaneous apoptosis following knockdown of Reptin in a variety of HCC cells occurred whether p53 was wild-type or mutated.8
Pontin also seems to act as an antiapoptotic factor. Indeed, a dominant-negative mutant of Pontin, devoid of ATPase activity, potentiates the apoptotic activity of c-myc and of E2F1 (10). We found that, similar to Reptin, the knockdown of Pontin in HCC cells led to spontaneous apoptosis.9
As mentioned above, Pontin and Reptin interact with Hint1, which triggers apoptosis by binding to and activating, notably, the Bax promoter (26). An attractive hypothesis is that the increased cytoplasmic levels of both proteins observed in some malignancies may sequester Hint1 in the cytoplasm, preventing it from regulating proapoptotic gene expression.
Altogether, Pontin and Reptin favor cell proliferation and inhibit apoptosis, properties well in line with their supposed roles in cancer.
|
Pontin and Reptin as Therapeutic Targets?
|
|---|
As mentioned above, decreased expression of either Pontin or Reptin results in reduced tumor cell growth and increased apoptosis in vitro (4).10 We have also found that decreasing Reptin expression results in growth arrest of established tumors in xenograft experiments in mice.11 Thus, these proteins may qualify as therapeutic targets. It is also interesting to note that Reptin and Pontin are endowed with an ATPase activity, shown to be required for most of their known functions, which could be targeted by specific inhibitors.
|
Conclusion
|
|---|
Pontin and Reptin remain intriguing proteins that, given their alleged functions, seem to be involved in carcinogenesis at a multitude of steps. Much remains to be understood about them, but one of the most challenging issues may be the understanding of their respective roles. Indeed, although they are most often found in the same complexes, this is not always the case (12). In addition, both proteins have been evolutionarily conserved, suggesting that they have distinctive functions, which is supported by the finding that the deficiency of one cannot be rescued by the expression of the other (9). It is likely that both the nature of the multimeric complexes they form and the partners they interact with will dictate their function in a variety of cellular processes relevant for carcinogenesis (Fig. 1
).
View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1. An illustration depicting the context-dependent complexity of Pontin and Reptin functions. Depending on their multimeric status (monomers, homooligomers, or heterooligomers) and their main interaction partners (within the yellow circle), they are involved in multiple biological processes (green circle). However, the detailed molecular mechanisms behind these activities have to be deciphered.
|
|
|
Disclosure of Potential Conflicts of Interest
|
|---|
No potential conflicts of interest were disclosed.
|
Acknowledgments
|
|---|
Grant support: Institut National du Cancer, Association pour la Recherche sur le Cancer, Agence Nationale pour la Recherche sur le SIDA et les Hépatites Virales, and Ligue Nationale Contre le Cancer (J. Rosenbaum), and the Deutsche Forschungsgemeinschaft and the Sonnenfeld-Stiftung (O. Huber).
|
Footnotes
|
|---|
4 Unpublished data. 
5 http://www.oncomine.org
6 Unpublished data.
7 Unpublished data.
8 Unpublished data.
9 Haurie V, Ménard L, Taras D, and Rosenbaum J, in preparation.
10 Unpublished observations.
11 Ménard L, Taras D, Nicou A, Haurie V, and Rosenbaum J, in preparation.
Received 2/16/08.
Revised 5/ 6/08.
Accepted 5/28/08.
|
References
|
|---|
- Gallant P. Control of transcription by Pontin and Reptin. Trends Cell Biol 2007;17:187–92.[CrossRef][Medline]
- Sigala B, Edwards M, Puri T, Tsaneva IR. Relocalization of human chromatin remodeling cofactor TIP48 in mitosis. Exp Cell Res 2005;310:357–69.[CrossRef][Medline]
- Blanc J, Lalanne C, Plomion C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005;5:3778–89.[CrossRef][Medline]
- Rousseau B, Menard L, Haurie V, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007;46:1108–18.[CrossRef][Medline]
- Lauscher JC, Loddenkemper C, Kosel L, et al. Increased pontin expression in human colorectal cancer tissue. Hum Pathol 2007;38:978–85.[CrossRef][Medline]
- Dehan E, Ben-Dor A, Liao W, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007;56:175–84.[CrossRef][Medline]
- Bauer A, Huber O, Kemler R. Pontin52, an interaction partner of β-catenin, binds to the TATA box binding protein. Proc Natl Acad Sci U S A 1998;95:14787–92.[Abstract/Free Full Text]
- Bauer A, Chauvet S, Huber O, et al. Pontin52 and reptin52 function as antagonistic regulators of β-catenin signalling activity. EMBO J 2000;19:6121–30.[CrossRef][Medline]
- Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000;5:321–30.[CrossRef][Medline]
- Dugan KA, Wood MA, Cole MD. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis. Oncogene 2002;21:5835–43.[CrossRef][Medline]
- Feng Y, Lee N, Fearon ER. TIP49 regulates β-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res 2003;63:8726–34.[Abstract/Free Full Text]
- Kim JH, Kim B, Cai L, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 2005;434:921–6.[CrossRef][Medline]
- Kim JH, Choi HJ, Kim B, et al. Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat Cell Biol 2006;8:631–9.[CrossRef][Medline]
- Kim JH, Lee JM, Nam HJ, et al. SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells. Proc Natl Acad Sci U S A 2007;104:20793–8.[Abstract/Free Full Text]
- Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000;102:463–73.[CrossRef][Medline]
- Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160–6.[Abstract/Free Full Text]
- Jha S, Shibata E, Dutta A. Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the down-regulation of phosphorylation on H2AX after DNA damage. Mol Cell Biol 2008;28:2690–700.[Abstract/Free Full Text]
- Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-β-catenin-mediated transcription. J Cell Sci 2005;118:3117–29.[Abstract/Free Full Text]
- Cho SG, Bhoumik A, Broday L, et al. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol Cell Biol 2001;21:8398–413.[Abstract/Free Full Text]
- Etard C, Gradl D, Kunz M, Eilers M, Wedlich D. Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1. Mech Dev 2005;122:545–56.[CrossRef][Medline]
- Bellosta P, Hulf T, Balla Diop S, et al. Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. Proc Natl Acad Sci U S A 2005;102:11799–804.[Abstract/Free Full Text]
- Lim CR, Kimata Y, Ohdate H, et al. The Saccharomyces cerevisiae RuvB-like protein, Tih2p, is required for cell cycle progression and RNA polymerase II-directed transcription. J Biol Chem 2000;275:22409–17.[Abstract/Free Full Text]
- Chan HM, Narita M, Lowe SW, Livingston DM. The p400 E1A-associated protein is a novel component of the p53
p21 senescence pathway. Genes Dev 2005;19:196–201.[Abstract/Free Full Text] - Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 2008;132:945–57.[CrossRef][Medline]
- Tyteca S, Vandromme M, Legube G, Chevillard-Briet M, Trouche D. Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO J 2006;25:1680–9.[CrossRef][Medline]
- Weiske J, Huber O. The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem 2006;281:27356–66.[Abstract/Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
S. Rashid, I. Pilecka, A. Torun, M. Olchowik, B. Bielinska, and M. Miaczynska
Endosomal Adaptor Proteins APPL1 and APPL2 Are Novel Activators of {beta}-Catenin/TCF-mediated Transcription
J. Biol. Chem.,
July 3, 2009;
284(27):
18115 - 18128.
[Abstract]
[Full Text]
[PDF]
|
|
|
Top
Abstract
Introduction
